• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Device Problems Migration or Expulsion of Device (1395); Appropriate Term/Code Not Available (3191)
Patient Problems Erosion (1750); Granuloma (1876); Unspecified Infection (1930); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Date sent to the fda: 07/21/2017.(b)(4).If the device or further details are received at the later date a supplemental medwatch will be sent.No specific patient information regarding additional events has been provided.Attempts are being made to obtain the following information.If further details are received at the later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon products / vicryl suture, caused or contributed to: recurrence, suture granuloma, combo: antibiotic, steroid ointment, suture exposure, infection, iodine sterilization of the skin of the upper eyelid, reoperation ? if yes, provide details of event and specific suture product type.Can specific patient demographics be provided for each of the subjects of this article? if yes, please include: date of procedure, where procedure was performed, specific medical/surgical intervention per patient, product involved, pre-existing conditions.Are the product code and lot numbers available for devices used vicryl suture?.
 
Event Description
It was reported in a journal article that the patient underwent a frontalis suspension with the open technique fox procedure between (b)(6) 2010 and (b)(6) 2013 and the suture was used for brow and the eyelid incision closures.Following the procedure, the patient possibly experienced partial or complete recurrence, suture granuloma at the middle suprabrow incision, which responded well to a combination of antibiotic and steroid ointment with no need for surgical removal, suture exposure at the middle suprabrow incision and/or at the skin crease incision within an average time of two months postoperatively.It was possible that the patient underwent a reoperation carried out under a complete umbrella of broad-spectrum antibiotics with closure of the wound at two different layers.It was also reported that the patient possibly experienced infection which was treated with iodine sterilization of the skin of the upper eyelid, topical antibiotic ointment, and systemic antibiotic and underwent a reoperation after skin infection was controlled.It was possible that the patient had overcorrection where the upper eyelid returned to normal position without massage or surgical intervention eight weeks after the procedure.During this period, only lubricants were used.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICRYL POLYGLACTIN 910 SUTURE
Type of Device
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
UNKNOWN
unknown
x
Manufacturer Contact
darlene kyle
route 22 west po box 151
somerville, NJ 08876
9082182792
MDR Report Key6733928
MDR Text Key80753785
Report Number2210968-2017-33073
Device Sequence Number1
Product Code GAM
Combination Product (y/n)N
PMA/PMN Number
K022269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/26/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-